Document Detail

Percutaneous aortic valve replacement in a 65-year old patient with thalassemia intermedia: A case report.
MedLine Citation:
PMID:  20888299     Owner:  NLM     Status:  In-Process    
Thalassaemia is an inherited hemoglobin disorder resulting in chronic hemolytic anemia. Organ damage caused by iron overload represents the major cause of illness and the heart complications secondary to extensive myocardial iron overload are the leading cause of mortality. These patients are generally not considered as candidates for heart transplantation. We report a case of a patient with thalassemia intermedia (TI) with severe cardiac dysfunction and severe aortic stenosis who underwent percutaneous aortic valve replacement (PARV). PARV was a safe and a valid therapeutic approach dramatically to improve the clinical evolution of cardiomyopathies in our patient.
Rosamaria Rosso; Gian Paolo Ussia; Benedetta Ximenes; Corrado Tamburino; Turiddu Lombardo
Related Documents :
11025569 - Congenital severe aortic stenosis with congestive heart failure in late childhood and a...
6613879 - Aortic valve replacement in childhood: evaluation of left ventricular function by elect...
12963179 - Pulmonary autografts in patients with severe left ventricular dysfunction.
3806929 - Pathogenetic mechanism of stenosis in the intramural coronary artery.
12776019 - Transesophageal echocardiographic evaluation of perioperative systolic murmur in aortic...
15172299 - Marfan syndrome as a predisposing factor for traumatic aortic insufficiency.
17079819 - Evidence that myocardial na/i symporter gene imaging does not perturb cardiac function.
8084969 - Snoring and the severity of coronary artery disease in men.
24591219 - Malonyl coa: a promising target for the treatment of cardiac disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis     Volume:  43     ISSN:  1473-0502     ISO Abbreviation:  Transfus. Apher. Sci.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101095653     Medline TA:  Transfus Apher Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  189-92     Citation Subset:  T    
Copyright Information:
Copyright © 2010. Published by Elsevier Ltd.
Department of Thalassemia, S. Bambino Hospital, Catania, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optimization of inhaled therapies for tuberculosis: The role of macrophages and dendritic cells.
Next Document:  World Apheresis Association.